Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Nat Rev Immunol. 2018 May;18(5):309-324. doi: 10.1038/nri.2017.142. Epub 2018 Jan 22.
Fourteen years have passed since nuclear factor-κB (NF-κB) was first shown to serve as a molecular lynchpin that links persistent infections and chronic inflammation to increased cancer risk. The young field of inflammation and cancer has now come of age, and inflammation has been recognized by the broad cancer research community as a hallmark and cause of cancer. Here, we discuss how the initial discovery of a role for NF-κB in linking inflammation and cancer led to an improved understanding of tumour-elicited inflammation and its effects on anticancer immunity.
自核因子-κB(NF-κB)首次被证明作为将持续性感染和慢性炎症与癌症风险增加联系起来的分子关键因素以来,已经过去了 14 年。炎症与癌症这一新兴领域如今已经成熟,炎症已被广泛的癌症研究界公认为癌症的一个标志和原因。在这里,我们讨论了 NF-κB 在将炎症与癌症联系起来的作用的最初发现如何导致对肿瘤引发的炎症及其对抗癌免疫的影响的理解的提高。
Nat Rev Immunol. 2018-1-22
Nat Rev Immunol. 2005-10
Curr Aging Sci. 2009-12
Semin Cell Dev Biol. 2017-8-2
J Natl Cancer Inst. 2009-8-19
Am J Reprod Immunol. 2007-2
Cell Signal. 2009-3
Nat Rev Immunol. 2017-9
Nihon Rinsho. 2015-5
Nat Rev Cancer. 2025-9-8
Cancer Cell. 2017-12-11
Nature. 2017-11-16
Semin Cell Dev Biol. 2017-8-2
J Cancer Metastasis Treat. 2017
Nat Rev Immunol. 2017-9